Published in J Pediatr on July 01, 2003
Congenital Cytomegalovirus: Efficacy of Antiviral Treatment (CONCERT 2) | NCT02005822
Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med (2015) 3.75
Antiviral drug resistance of human cytomegalovirus. Clin Microbiol Rev (2010) 2.70
The "silent" global burden of congenital cytomegalovirus. Clin Microbiol Rev (2013) 2.28
Washing our hands of the congenital cytomegalovirus disease epidemic. BMC Public Health (2005) 2.13
Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention. Clin Microbiol Rev (2009) 1.90
Treatment of symptomatic congenital cytomegalovirus infection with intravenous ganciclovir followed by long-term oral valganciclovir. Eur J Pediatr (2010) 1.64
Congenital cytomegalovirus infection: new prospects for prevention and therapy. Pediatr Clin North Am (2013) 1.40
Selecting neonates with congenital cytomegalovirus infection for ganciclovir therapy. Eur J Pediatr (2006) 1.39
Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol (2009) 1.32
Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategies. J Antimicrob Chemother (2009) 1.30
The impact of differential antiviral immunity in children and adults. Nat Rev Immunol (2012) 1.21
Cytomegalovirus shedding and delayed sensorineural hearing loss: results from longitudinal follow-up of children with congenital infection. Pediatr Infect Dis J (2009) 1.19
The genetic basis of human cytomegalovirus resistance and current trends in antiviral resistance analysis. Infect Disord Drug Targets (2011) 1.10
Antiviral therapy for herpesvirus central nervous system infections: neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection. Antiviral Res (2009) 1.09
Cytomegalovirus vaccine development. Curr Top Microbiol Immunol (2008) 1.08
Clinical findings and adverse outcome in neonates with symptomatic congenital cytomegalovirus (SCCMV) infection. Eur J Pediatr (2006) 1.01
Early diagnosis of neonatal cholestatic jaundice: test at 2 weeks. Can Fam Physician (2009) 0.99
Viral causes of hearing loss: a review for hearing health professionals. Trends Hear (2014) 0.99
Cyclopropavir inhibits the normal function of the human cytomegalovirus UL97 kinase. Antimicrob Agents Chemother (2011) 0.98
Oral valganciclovir treatment in newborns with symptomatic congenital cytomegalovirus infection. Eur J Clin Microbiol Infect Dis (2009) 0.97
Universal newborn screening for congenital CMV infection: what is the evidence of potential benefit? Rev Med Virol (2014) 0.96
Prevention of maternal cytomegalovirus infection: current status and future prospects. Int J Womens Health (2010) 0.95
The search for new therapies for human cytomegalovirus infections. Virus Res (2010) 0.95
Emerging Role of Zika Virus in Adverse Fetal and Neonatal Outcomes. Clin Microbiol Rev (2016) 0.94
Screening for congenital cytomegalovirus infection using newborn urine samples collected on filter paper: feasibility and outcomes from a multicentre study. BMJ Open (2011) 0.94
Ganciclovir for severe cytomegalovirus primary infection in an immunocompetent child. Eur J Clin Microbiol Infect Dis (2004) 0.92
Artemisinin-derived dimer diphenyl phosphate is an irreversible inhibitor of human cytomegalovirus replication. Antimicrob Agents Chemother (2012) 0.91
Prevention of maternal and congenital cytomegalovirus infection. Clin Obstet Gynecol (2012) 0.90
Congenital hearing impairment. Pediatr Radiol (2006) 0.88
Real-time PCR assay using specimens on filter disks as a template for detection of cytomegalovirus in urine. J Clin Microbiol (2007) 0.88
Educating women about congenital cytomegalovirus: assessment of health education materials through a web-based survey. BMC Womens Health (2014) 0.87
Congenital cytomegalovirus infection in high-risk Canadian infants: Report of a pilot screening study. Can J Infect Dis Med Microbiol (2010) 0.87
The use of antiviral drugs during the neonatal period. Clin Perinatol (2012) 0.86
Evaluating the feasibility of integrating salivary testing for congenital CMV into the Newborn Hearing Screening Programme in the UK. Eur J Pediatr (2015) 0.86
Cytomegalovirus infection in pregnancy: should all women be screened? Rev Obstet Gynecol (2010) 0.85
Immunobiology of congenital cytomegalovirus infection of the central nervous system—the murine cytomegalovirus model. Cell Mol Immunol (2014) 0.85
Jaundice in a neonate with congenital diaphragmatic hernia. Paediatr Child Health (2009) 0.85
Newborn hearing screening programme in Belgium: a consensus recommendation on risk factors. BMC Pediatr (2015) 0.84
Establishment of a cell-based assay for screening of compounds inhibiting very early events in the cytomegalovirus replication cycle and characterization of a compound identified using the assay. Antimicrob Agents Chemother (2008) 0.84
Asymptomatic DNAemia heralds CMV-associated NEC: case report, review, and rationale for preemption. Pediatrics (2013) 0.84
Cyclic cidofovir (cHPMPC) prevents congenital cytomegalovirus infection in a guinea pig model. Virol J (2006) 0.84
Murine CMV-induced hearing loss is associated with inner ear inflammation and loss of spiral ganglia neurons. PLoS Pathog (2015) 0.84
Incidence and impact of CMV infection in very low birth weight infants. Pediatrics (2014) 0.83
Congenital cytomegalovirus infection manifesting as neonatal persistent pulmonary hypertension: report of two cases. Pulm Med (2011) 0.83
Letermovir Treatment of Human Cytomegalovirus Infection Antiinfective Agent. Drugs Future (2013) 0.83
A model of human cytomegalovirus infection in severe combined immunodeficient mice. Antiviral Res (2007) 0.83
Congenital cytomegalovirus infection in pediatric hearing loss. Arch Otolaryngol Head Neck Surg (2011) 0.83
Advances in the prevention and treatment of congenital cytomegalovirus infection. Curr Opin Pediatr (2016) 0.82
Infections and Brain Development. Obstet Gynecol Surv (2015) 0.82
Herpesvirus infections of the central nervous system in immunocompromised patients. Ther Adv Neurol Disord (2012) 0.81
Cytomegalovirus antivirals and development of improved animal models. Expert Opin Drug Metab Toxicol (2011) 0.81
Expression of the human cytomegalovirus UL97 gene in a chimeric guinea pig cytomegalovirus (GPCMV) results in viable virus with increased susceptibility to ganciclovir and maribavir. Antiviral Res (2008) 0.81
Oral hexadecyloxypropyl-cidofovir therapy in pregnant guinea pigs improves outcome in the congenital model of cytomegalovirus infection. Antimicrob Agents Chemother (2010) 0.80
Detection of cytomegalovirus DNA in preserved umbilical cords from patients with sensorineural hearing loss. Eur Arch Otorhinolaryngol (2008) 0.80
Congenital cytomegalovirus (CMV) infections: hats off to Alabama. J Pediatr (2003) 0.80
Incidence of CMV co-infection in HIV-positive women and their neonates in a tertiary referral centre: a cohort study. Med Microbiol Immunol (2015) 0.80
Universal newborn hearing screening in 2010. Curr Opin Otolaryngol Head Neck Surg (2010) 0.80
Awareness of Cytomegalovirus Infection among Pregnant Women in Geneva, Switzerland: A Cross-sectional Study. Int J Environ Res Public Health (2015) 0.79
Congenital cytomegalovirus infection: update on management strategies. Curr Treat Options Neurol (2008) 0.78
Perinatal cytomegalovirus and varicella zoster virus infections: epidemiology, prevention, and treatment. Clin Perinatol (2014) 0.78
Cytomegalovirus infection in pregnancy: review of the literature. J Prenat Med (2011) 0.78
Beta2-microglobulin concentrations in cerebrospinal fluid correlate with neuroimaging findings in newborns with symptomatic congenital cytomegalovirus infection. Eur J Pediatr (2006) 0.78
Reduced frequencies of polyfunctional CMV-specific T cell responses in infants with congenital CMV infection. J Clin Immunol (2015) 0.78
Valganciclovir for treatment of congenital cytomegalovirus infection. Eur J Pediatr (2006) 0.78
Emergence of antiviral resistance during oral valganciclovir treatment of an infant with congenital cytomegalovirus (CMV) infection. J Clin Virol (2013) 0.77
Awareness of cytomegalovirus and risk factors for susceptibility among pregnant women, in Montreal, Canada. BMC Pregnancy Childbirth (2016) 0.77
Public health and laboratory considerations regarding newborn screening for congenital cytomegalovirus. J Inherit Metab Dis (2010) 0.77
Long-term outcomes of children with symptomatic congenital cytomegalovirus disease. J Perinatol (2017) 0.77
Pyrosequencing allows the detection of emergent ganciclovir resistance mutations after HCMV infection. Med Microbiol Immunol (2010) 0.76
Growth and development of infants with asymptomatic congenital cytomegalovirus infection. Yonsei Med J (2009) 0.76
Why CMV is a candidate for elimination and then eradication. J Virus Erad (2016) 0.76
Pathological changes of cochlear in deaf mice at different time after mouse cytomegalovirus infection. Int J Clin Exp Med (2015) 0.75
Dried blood spots PCR assays to screen congenital cytomegalovirus infection: a meta-analysis. Virol J (2015) 0.75
Severe late-onset multisystem cytomegalovirus infection in a premature neonate previously treated for congenital infection. BMC Pediatr (2013) 0.75
Safety of alternative antiviral agents for neonatal herpes simplex virus encephalitis and disseminated infection. J Pediatr Pharmacol Ther (2014) 0.75
Therapeutic drug monitoring of ganciclovir for postnatal cytomegalovirus infection in an extremely low birth weight infant: a case report. BMC Pediatr (2016) 0.75
Cytomegalovirus (CMV) Infection Causes Degeneration of Cochlear Vasculature and Hearing Loss in a Mouse Model. J Assoc Res Otolaryngol (2016) 0.75
Aetiologic diagnosis of hearing loss in children identified through newborn hearing screening testing. Acta Otorhinolaryngol Ital (2016) 0.75
Cytomegalovirus in pregnancy and the neonate. F1000Res (2017) 0.75
Ganciclovir penetrates into the cerebrospinal fluid of an infant with congenital cytomegalovirus infection. Ital J Pediatr (2015) 0.75
Gastrointestinal presentation and outcome of perinatal cytomegalovirus infection. BMJ Case Rep (2013) 0.75
Deafness in children: a national survey of aetiological investigations. BMJ Open (2012) 0.75
Advances in Pediatric Pharmacology, Therapeutics, and Toxicology. Adv Pediatr (2016) 0.75
Treatment of perinatal viral infections to improve neurologic outcomes. Pediatr Res (2016) 0.75
Ganciclovir therapy for neonates with congenital cytomegalovirus infection. Eur J Pediatr (2006) 0.75
Longitudinal Kinetics of Cytomegalovirus-Specific T-Cell Immunity and Viral Replication in Infants With Congenital Cytomegalovirus Infection. J Pediatric Infect Dis Soc (2014) 0.75
[Viral infections of the fetus and newborn infant]. Pediatr Med Chir (2009) 0.75
Primary Human Cytomegalovirus (HCMV) Infection in Pregnancy. Dtsch Arztebl Int (2017) 0.75
Cytomegalovirus and paediatric HIV infection. J Virus Erad (2016) 0.75
Efficacy and Mechanism of Action of Low Dose Emetine against Human Cytomegalovirus. PLoS Pathog (2016) 0.75
Cytomegalovirus infection among infants in California neonatal intensive care units, 2005-2010. J Perinat Med (2014) 0.75
Congenital Cytomegalovirus infection: advances and challenges in diagnosis, prevention and treatment. Ital J Pediatr (2017) 0.75
Determining the prevalence of cytomegalovirus infection in a cohort of preterm infants. J Neonatal Perinatal Med (2015) 0.75
Symptomatic Congenital Cytomegalovirus Infection in Children of Seropositive Women. Front Pediatr (2017) 0.75
Sensorineural Hearing Loss in a Patient Affected by Congenital Cytomegalovirus Infection: Is It Useful to Identify Comorbid Pathologies? J Pediatr Genet (2017) 0.75
Adjuvant therapy in biliary atresia: hopelessly optimistic or potential for change? Pediatr Surg Int (2017) 0.75
Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics (2010) 9.15
Practice guidelines for the management of bacterial meningitis. Clin Infect Dis (2004) 7.79
Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med (2010) 6.86
Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis (2006) 5.71
Early CPAP versus surfactant in extremely preterm infants. N Engl J Med (2010) 5.23
Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients. Clin Cancer Res (2005) 4.94
Clinical practice. Herpes zoster. N Engl J Med (2002) 4.72
Recommendations for the management of herpes zoster. Clin Infect Dis (2007) 4.33
Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection. JAMA (2010) 4.31
Varicella-zoster vaccine for the prevention of herpes zoster. N Engl J Med (2007) 3.92
Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics (2011) 3.84
The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis (2008) 3.79
Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med (2015) 3.75
Maternal immunity and prevention of congenital cytomegalovirus infection. JAMA (2003) 3.22
Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics (2009) 3.05
The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up. Ann Surg Oncol (2004) 2.99
Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics (2001) 2.91
Interval between births and risk of congenital cytomegalovirus infection. Clin Infect Dis (2004) 2.54
Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns. N Engl J Med (2011) 2.53
Predictors of death in infants hospitalized with pertussis: a case-control study of 16 pertussis deaths in Canada. J Pediatr (2003) 2.42
The prevalence of neonatal herpes simplex virus infection compared with serious bacterial illness in hospitalized neonates. J Pediatr (2008) 2.39
Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics (2001) 2.30
Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 "cherubism" mice. Cell (2007) 2.18
Oral acyclovir suppression and neurodevelopment after neonatal herpes. N Engl J Med (2011) 2.18
Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM. Mol Ther (2008) 2.17
Oral GS-5806 activity in a respiratory syncytial virus challenge study. N Engl J Med (2014) 2.07
High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin. J Hepatol (2010) 2.01
Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America. Clin Infect Dis (2004) 2.00
Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks' gestation. JAMA (2011) 1.92
Congenital cytomegalovirus infection: association between virus burden in infancy and hearing loss. J Pediatr (2005) 1.89
Neonatal candidiasis: epidemiology, risk factors, and clinical judgment. Pediatrics (2010) 1.86
Moving toward elimination of healthcare-associated infections: a call to action. Am J Infect Control (2010) 1.86
Pandemic influenza in Canadian children: a summary of hospitalized pediatric cases. Vaccine (2010) 1.86
Causes and timing of death in extremely premature infants from 2000 through 2011. N Engl J Med (2015) 1.74
Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis. Pediatr Infect Dis J (2003) 1.71
FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia. Blood (2008) 1.67
Hearing loss in children with congenital cytomegalovirus infection born to mothers with preexisting immunity. J Pediatr (2006) 1.66
Clinical activity of gemcitabine plus pertuzumab in platinum-resistant ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. J Clin Oncol (2009) 1.66
Burden of seasonal influenza in children with neurodevelopmental conditions. Pediatr Infect Dis J (2014) 1.63
Genotype prevalence and risk factors for severe clinical adenovirus infection, United States 2004-2006. Clin Infect Dis (2007) 1.63
Surveillance for influenza admissions among children hospitalized in Canadian immunization monitoring program active centers, 2003-2004. Pediatrics (2006) 1.59
Risk factors for congenital cytomegalovirus infection in the offspring of young women: exposure to young children and recent onset of sexual activity. Pediatrics (2006) 1.57
Herpes simplex virus encephalitis during suppressive therapy with acyclovir in a premature infant. Pediatrics (2005) 1.54
Early surfactant for neonates with mild to moderate respiratory distress syndrome: a multicenter, randomized trial. J Pediatr (2004) 1.53
Characterization of genetic and phenotypic diversity of invasive nontypeable Haemophilus influenzae. Infect Immun (2005) 1.53
Congenital cytomegalovirus infection: screening and treatment. J Pediatr (2010) 1.51
Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease. J Infect Dis (2008) 1.49
Oseltamivir pharmacokinetics, dosing, and resistance among children aged <2 years with influenza. J Infect Dis (2012) 1.49
A sliding-window weighted linkage disequilibrium test. Genet Epidemiol (2006) 1.47
Invasive disease due to nontypeable Haemophilus influenzae among children in Arkansas. J Clin Microbiol (2003) 1.46
Neurologic complications associated with influenza A in children during the 2003-2004 influenza season in Houston, Texas. Pediatrics (2004) 1.45
Evaluation and treatment of neonates with suspected late-onset sepsis: a survey of neonatologists' practices. Pediatrics (2002) 1.45
Outcomes in patients hospitalized for periapical abscess in the United States: an analysis involving the use of a nationwide inpatient sample. J Am Dent Assoc (2010) 1.43
Change in care among nonenrolled patients during and after a randomized trial. Pediatrics (2013) 1.42
A Randomized, Double-Blind, Placebo-Controlled Trial of Pleconaril for the Treatment of Neonates With Enterovirus Sepsis. J Pediatric Infect Dis Soc (2015) 1.42
2010 TNM staging system for cutaneous melanoma...and beyond. Ann Surg Oncol (2010) 1.42
Herpes Simplex Encephalitis: Lack of Clinical Benefit of Long-term Valacyclovir Therapy. Clin Infect Dis (2015) 1.41
Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety, and pharmacokinetics. Hepatology (2005) 1.40
Prognosis and determinants of outcome following locoregional or distant recurrence in patients with cutaneous melanoma. Ann Surg Oncol (2008) 1.39
Effect of adenine arabinoside on severe Herpesvirus hominis infections in man. 1973. J Infect Dis (2004) 1.39
The impact of childhood meningococcal serogroup C conjugate vaccine programs in Canada. Pediatr Infect Dis J (2009) 1.38
Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia. J Pain (2008) 1.38
Central nervous system infection in congenital syphilis. N Engl J Med (2002) 1.35
Comparison of the directigen flu A+B membrane enzyme immunoassay with viral culture for rapid detection of influenza A and B viruses in respiratory specimens. J Clin Microbiol (2004) 1.33
Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol (2009) 1.32
Detection of cytomegalovirus (CMV) DNA by polymerase chain reaction is associated with hearing loss in newborns with symptomatic congenital CMV infection involving the central nervous system. J Infect Dis (2004) 1.32
Medically attended pediatric influenza during the resurgence of the Victoria lineage of influenza B virus. Int J Infect Dis (2006) 1.29
The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000-2007. Vaccine (2009) 1.27
Polymorphisms of the cytomegalovirus (CMV)-encoded tumor necrosis factor-alpha and beta-chemokine receptors in congenital CMV disease. J Infect Dis (2002) 1.27
Outcome of penicillin-nonsusceptible Streptococcus pneumoniae meningitis: a nested case-control study. Pediatr Infect Dis J (2002) 1.26
Increased efficacy of an interleukin-12-secreting herpes simplex virus in a syngeneic intracranial murine glioma model. Neuro Oncol (2005) 1.26
Frequent detection of polyomaviruses in stool samples from hospitalized children. J Infect Dis (2005) 1.25
Invasive Haemophilus influenzae type b infections in vaccinated and unvaccinated children in Canada, 2001-2003. CMAJ (2005) 1.24
Invasive infections caused by haemophilus influenzae serotypes in twelve Canadian IMPACT centers, 1996-2001. Pediatr Infect Dis J (2007) 1.23
Neurodevelopmental outcome of extremely low birth weight infants with Candida infection. J Pediatr (2013) 1.22